4D Molecular Therapeutics (FDMT) Other Non-Current Liabilities (2019 - 2026)
4D Molecular Therapeutics' Other Non-Current Liabilities came in at $384,000 for Q2 2026, up 15.0% from $334,000 a year earlier and up 3.8% from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, 4D Molecular Therapeutics' Other Non-Current Liabilities was $358,000, down 12.7% from FY2024.
- Other Non-Current Liabilities carries a five-year compound annual growth rate of -28.0% (FY2020 to FY2025).
- Going back by year, Other Non-Current Liabilities was $410,000 in FY2024 (+11.1%), $369,000 in FY2023 (+74.1%), $212,000 in FY2022 (-0.9%) and $214,000 in FY2021 (-88.4%).
- The Q2 2026 figure represents the highest quarterly Other Non-Current Liabilities since Q4 2024.
- Year-over-year, Other Non-Current Liabilities increased in four of the last eight quarters, with an average decline of 0.3%.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2024 (growth of 80.2%), and the weakest in Q3 2022 (a decline of 88.7%).
- Business Quant data shows FDMT's Other Non-Current Liabilities at $370,000 (Q1 2026), $358,000 (Q4 2025) and $345,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.37 Bn | 1,139.96 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 645.23 Bn | 565.09 Bn | 17.30 Bn |
| 3 | AbbVie | 502.25 Bn | 475.37 Bn | 12.70 Bn |
| 4 | Merck | 361.34 Bn | 315.71 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.82 Bn | 266.81 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.91 Bn | 241.60 Bn | 12.86 Bn |
| 7 | Amgen | 242.39 Bn | 197.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.55 Bn | 167.74 Bn | 6.22 Bn |
| 9 | Pfizer | 172.05 Bn | 118.70 Bn | 10.94 Bn |
| 10 | 4D Molecular Therapeutics | 876.64 Mn | -583.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 485,000.00 |
| Mar 31, 2026 | 491,000.00 |
| Dec 31, 2025 | 496,000.00 |
| Sep 30, 2025 | 489,000.00 |
| Jun 30, 2025 | 495,000.00 |
| Mar 31, 2025 | 499,000.00 |
| Dec 31, 2024 | 603,000.00 |
| Sep 30, 2024 | 592,000.00 |
| Jun 30, 2024 | 596,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 617,000.00 |
| Sep 30, 2023 | 389,000.00 |
| Jun 30, 2023 | 236,000.00 |
| Mar 31, 2023 | 248,000.00 |
| Dec 31, 2022 | 233,000.00 |
| Sep 30, 2022 | 236,000.00 |
| Jun 30, 2022 | 234,000.00 |
| Mar 31, 2022 | 236,000.00 |
| Dec 31, 2021 | 334,000.00 |
| Sep 30, 2021 | 1.89 Mn |
API Access
4D Molecular Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();